@article{2eaefc4add1d4bbfa65568da1e489798,
title = "Oncolytic Adenovirus Type 3 Coding for CD40L Facilitates Dendritic Cell Therapy of Prostate Cancer in Humanized Mice and Patient Samples",
keywords = "adenovirus 3, CD40 ligand, dendritic cells (DCs), prostate cancer, tumor microenvironment, PHASE-I, IMMUNE-RESPONSE, GENE-TRANSFER, DESMOGLEIN 2, IMMUNOTHERAPY, LIGAND, DIFFERENTIATION, PROGRESSION, VACCINATION, MECHANISMS, 11832 Microbiology and virology, 318 Medical biotechnology, 1184 Genetics, developmental biology, physiology",
author = "Sadia Zafar and Saru Basnet and Inga-Maria Launonen and Quixabeira, {Dafne Carolina Alves} and Joao Santos and Otto Hemminki and Minna Malmstedt and Victor Cervera-Carrascon and Pasi Aronen and Riikka Kalliokoski and Riikka Havunen and Antti Rannikko and Tuomas Mirtti and Mika Matikainen and Anna Kanerva and Akseli Hemminki",
year = "2021",
month = feb,
day = "1",
doi = "10.1089/hum.2020.222",
language = "English",
volume = "32",
pages = "192--202",
journal = "Human Gene Therapy",
issn = "1043-0342",
publisher = "Mary Ann Liebert Inc.",
number = "3-4",
}